摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3-azido-4,6-O-benzylidene-3-deoxy-α-D-altropyranoside | 134526-04-8

中文名称
——
中文别名
——
英文名称
methyl 3-azido-4,6-O-benzylidene-3-deoxy-α-D-altropyranoside
英文别名
(2R,4aR,6S,7S,8S,8aS)-8-azido-6-methoxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-ol
methyl 3-azido-4,6-O-benzylidene-3-deoxy-α-D-altropyranoside化学式
CAS
134526-04-8
化学式
C14H17N3O5
mdl
——
分子量
307.306
InChiKey
RNDFEGLTMSTFOF-JJEKRJTGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    71.5
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Inter- and intramolecular reactions of 1-deoxy-1-thio-1,6-anhydrosugars with α-diazoesters: synthesis of the tagetitoxin core by photochemical ylide rearrangement
    作者:Anne J. Price Mortimer、Julien R. H. Plet、Oluwafunsho A. Obasanjo、Nikolas Kaltsoyannis、Michael J. Porter
    DOI:10.1039/c2ob26308d
    日期:——
    intermediacy of sulfur ylides, has been proposed as a route for the synthesis of the tagetitoxin skeleton. Intermolecular reactions of such thioanhydrosugars with diazoesters afford a range of undesired products derived from the initially formed ylide, whereas use of an intramolecular process generates stable ylides which can be converted to the tagetitoxin skeleton by photo-Stevens rearrangement. Computational
    已经提出了由金属卡宾介导并通过硫酰化物的中间进行的1-脱氧-1-硫代-1,6-脱水糖的单碳环膨胀,作为合成塔格毒素框架的途径。此类硫代脱水糖与重氮酸酯的分子间反应提供了一系列源自最初形成的叶立德的不希望有的产物,而使用分子内过程会生成稳定的叶立德,这些叶立德可以通过光-史蒂文斯重排而转化为塔格毒素框架。使用密度泛函理论的计算研究表明,光化学重排可能通过均相-重组途径进行。
  • [EN] AN EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM<br/>[FR] PROCÉDÉ EFFICACE ET EXTENSIBLE DE FABRICATION DE FONDAPARINUX SODIQUE
    申请人:RELIABLE BIOPHARMACEUTICAL CORP
    公开号:WO2013115817A1
    公开(公告)日:2013-08-08
    The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    本发明涉及一种用于合成因子Xa抗凝剂Fondaparinux及相关化合物的过程。此外,该发明还涉及用于合成Fondaparinux及相关化合物的各种中间体的高效可扩展过程。
  • Fluorination of 2-hydroxy-hexopyranosides by DAST: towards formyl C-glycofuranosides from equatorial-2-OH methyl hexopyranosides
    作者:Yolanda Vera-Ayoso、Pastora Borrachero、Francisca Cabrera-Escribano、Ana T. Carmona、Manuel Gómez-Guillén
    DOI:10.1016/j.tetasy.2003.11.034
    日期:2004.2
    Reaction of diversely configured and substituted, unbranched methyl D-hexopyranosides with the DAST in dichloromethane or acetonitrile led to normal substitution products and/or rearranged fluoro compounds (ring-contracted 2,5-anhydro-1-fluoro-1-I-methylhexitol derivatives, 2-methoxy-D-hexopyranosyl fluorides, and, for some 3-azido substrates, rearranged 2-azido-3-fluoro-D-hexopyranosides). When the reaction was performed in acetonitrile, the solvent participation as a nucleophile (Ritter reaction) was observed in one case. For a 2,4-unprotected 3-azido substrate, 2,3-dehydration and fluorination at C(4), the latter with epimerization, took place. F-19/H-1 and F-19/C-13 coupling constant values were systematically applied to discriminate between isomeric structures for fluorinated products, and for some, previously described, coming from five 3-branched-chain D- or L-hexopyranosides, thus discarding the previously reported structural assignment. From the synthetic point of view, the most outstanding result was the preparation of 2,5-anhydro-1-fluoro-1-O-methylhexitols, showing a latent formyl group functionality, a transformation, which was achieved in one case. A rationalization for the formation of the different types of product is also proposed. (C) 2003 Elsevier Ltd. All rights reserved.
  • Benzylidene Acetal Protecting Group as Carboxylic Acid Surrogate: Synthesis of Functionalized Uronic Acids and Sugar Amino Acids
    作者:Amit Banerjee、Soundararasu Senthilkumar、Sundarababu Baskaran
    DOI:10.1002/chem.201503998
    日期:2016.1.18
    Direct oxidation of the 4,6‐O‐benzylidene acetal protecting group to C‐6 carboxylic acid has been developed that provides an easy access to a wide range of biologically important and synthetically challenging uronic acid and sugar amino acid derivatives in good yields. The RuCl3–NaIO4‐mediated oxidative cleavage method eliminates protection and deprotection steps and the reaction takes place under
    已开发出将4,6- O-亚苄基乙缩醛保护基直接氧化为C-6羧酸的方法,该方法可轻松获得大量具有重要生物学意义且具有合成挑战性的糖醛酸和糖氨基酸衍生物,且收率高。RuCl 3 -NaIO 4介导的氧化裂解方法消除了保护和脱保护步骤,并且反应在温和的条件下进行。在有效合成六碳唾液酸类似物和带有糖醛酸的二糖(包括糖胺聚糖类似物)时,利用了亚苄基乙缩醛作为羧酸的保护基和来源的双重作用。
  • 3-Amino-5-C-phenyl-d-altrofuranose and 3-amino-5-C-[3-carboxy-4-(carboxymethyl)-2-oxo-3-cyclohexen-1-yl]-d-altrofuranose, possible intermediates for synthesis of the anthracycline antibiotic decilorubicin
    作者:Toshio Izawa、Yoshio Nishimura、Shinichi Kondo
    DOI:10.1016/0008-6215(91)84152-5
    日期:1991.4
查看更多

同类化合物

苯甲基-2-乙酰氨基-4,6-O-苯亚甲基-2-脱氧-Alpha-D-吡喃葡萄糖苷 苯-1,2-二基二(磷羧酸酯) 苄基N-乙酰基-4,6-O-亚苄基-alpha-异胞壁酸 苄基4-氰基-4-脱氧-2,3-O-[(1S,2S)-1,2-二甲氧基-1,2-二甲基-1,2-乙二基]-beta-D-阿拉伯糖吡喃糖苷 苄基4,6-O-亚苄基吡喃己糖苷 苄基3-O-苄基-4,6-O-亚苄基吡喃己糖苷 苄基2-乙酰氨基-4,6-O-亚苄基-3-O-(羧甲基)-2-脱氧吡喃己糖苷 苄基(5Xi)-2-乙酰氨基-2-脱氧-4,6-O-异亚丙基-alpha-D-来苏-吡喃己糖苷 苄基 4,6-O-亚苄基-beta-D-吡喃半乳糖苷 苄基 4,6-O-亚苄基-alpha-D-吡喃半乳糖苷 苄基 4,6-O-亚苄基-2,3-二-O-苄基-alpha-D-吡喃半乳糖苷 苄基 2-乙酰氨基-2-脱氧-4,6-O-异亚丙基-beta-D-吡喃葡萄糖苷 苄基 2-乙酰氨基-2-脱氧-4,6-O-亚苄基-alpha-D-吡喃半乳糖苷 苄基 2-O-苄基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 苄基 2,3-二-O-苄基-4,6-O-亚苄基-beta-D-吡喃葡萄糖苷 苄基 2,3-二-O-(苯基甲基)-4,6-O-(苯基亚甲基)-ALPHA-D-吡喃甘露糖苷 甲基4-O,6-O-(苯基亚甲基)-2,3-二脱氧-alpha-D-赤式-吡喃己糖苷 甲基4,6-O-异亚丙基吡喃己糖苷 甲基4,6-O-异亚丙基-beta-D-吡喃半乳糖苷 甲基4,6-O-亚苄基-3-脱氧-3-硝基-beta-D-吡喃葡萄糖苷 甲基4,6-O-亚乙基-alpha-D-吡喃葡萄糖苷 甲基4,6-O-[(4-甲氧基苯基)亚甲基]-2,3-二-O-(苯基甲基)-ALPHA-D-吡喃葡萄糖苷 甲基4,6-O-[(4-甲氧基苯基)亚甲基]-2,3-二-O-(苯基甲基)-ALPHA-D-吡喃半乳糖苷 甲基3-O-苯甲酰基-4,6-O-亚苄基-beta-D-吡喃半乳糖苷 甲基3-O-苯甲酰基-4,6-O-亚苄基-alpha-D-吡喃葡萄糖苷 甲基2.3-二-O-苯甲酸基-4,6-O-亚苄基-β-D-喃葡萄苷 甲基2-乙酰氨基-4,6-O-亚苄基-2-脱氧吡喃己糖苷 甲基2-O-烯丙基-3-O-苄基-4,6-O-亚苄基吡喃己糖苷 甲基2,3-O-二烯丙基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 甲基-4,6-O-亚苄基-Α-D-吡喃葡糖苷 甲基-2,3-二-O-苯甲酰基-4,6-O-苯亚甲基-α-D-吡喃葡萄糖苷 甲基 4,6-O-亚苄基-β-D-吡喃葡萄糖苷 甲基 4,6-O-亚苄基-3-O-甲基-alpha-D-吡喃甘露糖苷 甲基 4,6-O-(苯基亚甲基)-alpha-D-吡喃葡萄糖苷 2-苯甲酸酯 甲基 4,6-O-(苯基亚甲基)-ALPHA-D-吡喃半乳糖苷二乙酸酯 甲基 3-O-苯甲酰基-4,6-O-亚苄基-beta-D-吡喃甘露糖苷 甲基 3-O-烯丙基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 甲基 2,3-二苯甲酰-4,6-O-亚苄基-beta-D-吡喃半乳糖苷 烯丙基-4,6-O-苯亚甲基-α-D-吡喃葡萄糖苷 烯丙基-4,6-O-亚苄基-beta-D-吡喃葡萄糖苷 山海绵酰胺A 对硝基苯基 2-乙酰氨基-4,6-O-亚苄基-2-脱氧-beta-D-吡喃葡萄糖苷 亚苄基葡萄糖 二甲基二烯丙基氯化铵-丙烯酰胺共聚物 乙基 4,6-O-亚苄基吡喃己糖苷 N-乙酰基-1-O-苄基-4,6-O-(亚苄基)-alpha-异胞壁酸甲酯 N-乙酰基-1-O-(苯基甲基)-4,6-O-(苯基亚甲基)-ALPHA-胞壁酸 N-[(4aR,6R,7R,8R,8aS)-6-苄氧基-8-羟基-2-苯基-4,4A,6,7,8,8A-六氢吡喃并[5,6-d][1,3]二恶英-7-基]乙酰胺 N-(6-烯丙氧基-8-羟基-2-苯基-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-7-基)乙酰胺 N-(6-烯丙氧基-8-羟基-2-苯基-4,4A,6,7,8,8A-六氢吡喃并[5,6-d][1,3]二恶英-7-基)乙酰胺